TELOR OPHTHALMIC PHARMACEUTICALS INC, 10-C, 1996-06-17

TELOR OPHTHALMIC PHARMACEUTICALS INC
10-C, 1996-06-17
PHARMACEUTICAL PREPARATIONS
Previous: WINTHROP RESOURCES CORP, S-2/A, 1996-06-17
Next: CASCADE COMMUNICATIONS CORP, S-3, 1996-06-17


<PAGE>
 
                      SECURITIES AND EXCHANGE COMMISSION

                            Washington, D.C. 20549

                                   FORM 10-C

                REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ

                         INTERDEALER QUOTATION SYSTEM

                 Filed pursuant to Section 13 or 15(d) of the

               Securities Exchange Act of 1934 and Rule 13a-176

                             or 15d-17 thereunder

                    TELOR OPHTHALMIC PHARMACEUTICALS, INC.
                (Exact name of issuer as specified in charter)

                        790 Turnpike Street - Suite 202
                      North Andover, Massachusetts 01845
                   (Address of principal executive offices)

Issuer's telephone number, including area code: (508) 681-1062

                   I. CHANGE IN NUMBER OF SHARES OUTSTANDING

     Indicate any change (increase or decrease) of 5% or more in the number of 
shares outstanding:

1.   Title of security: Common Stock
2.   Number of shares outstanding before the change: 786,002
3.   Number of shares outstanding after the change: 1,467,417
4.   Effective date of change: June 6, 1996
5.   Method of change:

     Specify method (such as merger, acquisition, exchange, distribution, stock 
     split, reverse split, acquisition of stock for treasury, etc.): Merger

     Give a brief description of the transaction: On June 6, 1996, the Issuer 
     merged with Occupational Health + Rehabilitation Inc ("OH + R"), with the
     Issuer being the surviving corporation. The Issuer changed its name to
     Occupational Health + Rehabilitation Inc. In connection with the merger,
     the Issuer issued approximately 681,415 shares of its common stock for all
     outstanding shares of OH + R capital stock, and, accordingly, the number of
     shares of Common Stock outstanding has increased from 786,002 to 1,467,417.
<PAGE>
 
                                      -2-

                          I. CHANGE IN NAME OF ISSUER

1.   Name prior to change: Telor Ophthalmic Pharmaceuticals, Inc.
2.   Name after change: Occupational Health + Rehabilitation Inc
3.   Effective date of charter amendment changing name: June 6, 1996
4.   Date of shareholder approval of change, if required: June 5, 1996

                                       TELOR OPHTHALMIC PHARMACEUTICALS, INC.
                                       N/K/A OCCUPATIONAL HEALTH + 
                                       REHABILITATION INC

Date: June 17, 1996                    By /s/ John C. Garbarino
                                          --------------------------------------
                                       John C. Garbarino
                                       Its President and Chief Executive Officer